Hanseatic Management Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-32
Closed -$24K 145
2021
Q3
$24K Buy
+32
New +$24K 0.04% 83
2020
Q3
Sell
-331
Closed -$149K 186
2020
Q2
$149K Hold
331
0.13% 112
2020
Q1
$116K Buy
+331
New +$122K 0.12% 122
2018
Q1
Sell
-2,556
Closed -$610K 444
2017
Q4
$610K Hold
2,556
0.61% 68
2017
Q3
$568K Sell
2,556
-1,377
-35% -$310K 0.64% 65
2017
Q2
$890K Buy
3,933
+350
+10% +$76.3K 0.45% 86
2017
Q1
$714K Buy
3,583
+3
+0.1% +$578 0.39% 106
2016
Q4
$653K Buy
+3,580
New +$610K 0.37% 113

Other funds holding BIO

Hanseatic Management Services's BIO Position: Q4 2021 in Review

Hanseatic Management Services sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 32 shares — an estimated $24K sold.

Hanseatic Management Services first reported a position in BIO in Q4 2016 and held it in 8 quarters. The position peaked at $890K in Q2 2017. 533 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

  • Hanseatic Management Services reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
  • Hanseatic Management Services sold 32 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $24K.
  • Hanseatic Management Services first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 8 quarters.
  • Hanseatic Management Services's Bio-Rad Laboratories Class A position peaked at $890K in Q2 2017.
  • 533 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on Hanseatic Management Services's 13F filing for Q4 2021, filed 9 Feb 2022.